Department of Gastroenterological Surgery

Message from the Director of the Department

We provide comprehensive surgical consultation and care in many specialties including esophageal surgery, gastric surgery, and colon and rectal surgery. Minimally invasive laparoscopic and thoracoscopic surgery and robotic surgery are actively performed for functional conservation and early recovery after surgery. Endoscopic treatment and chemotherapy are available options, when indicated.

藤原俊義

Director,
Department of Gastroenterological
Surgery
Toshiyoshi Fujiwara

Scope of Target Diseases

– Esophageal diseases: Endoscopic therapy, surgery, chemotherapy and radiotherapy for esophageal cancer, surgery for benign tumor such as leiomyoma, benign diseases such as reflux esophagitis, esophageal achalasia and esophageal diverticulum, and endoscopic therapy for pharyngeal cancer.
– Gastric diseases: Surgery and chemotherapy for gastric cancer and submucosal tumor such as gastrointestinal stromal tumor (GIST), and surgery for severe obesity, called bariatric surgery.
– Colorectal disease: Surgery, chemotherapy and radiotherapy for colorectal cancer, and surgery for small intestine tumor such as GIST, inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease, anal diseases such as hemorrhoid and rectal prolapse, and appendicitis.

Features and Description of Medical Care

– Esophageal surgery: As a leading hospital in Japan, we have many surgical cases for esophageal cancer. We strive for “less-invasiveness” in esophageal cancer surgery which is originally “high invasive” by introducing thoracoscopic laparoscopic and robotic surgery. We also have a good outcome in surgery for esophagogastric junction cancer from our use of an original procedure.
– Gastric surgery: We provide less-invasive and function-preserving surgery for gastric cancer by standardizing laparoscopic surgery, which currently accounts for more than 90%, and introducing laparoscopy and endoscopy cooperative surgery (LECS) and robotic surgery using the da Vinci Surgical System. We also aim at improved outcomes for advanced gastric cancer by the use of multimodal therapies including adjuvant chemotherapy before and after surgery.
– Colorectal surgery: We provide less-invasive laparoscopic surgery for colorectal cancer, notably hybrid surgery performed by two-team transperitoneally and transanally for low rectal cancer. We also provide less-invasive laparoscopic surgery with satisfactory cosmetic outcomes especially for IBD, which is common among young people.

For outpatient visits

Staff members of the respective specialties
– Esophageal surgery: Drs. Shirakawa, Noma, and Tanabe.
– Gastric surgery: Drs. Fujiwara, Kagawa, Nishizaki, Kuroda, and Kikuchi.
– Colorectal surgery: Drs. Kishimoto, Teraishi, Kondo, Yano, and Mori We provide the best possible medical treatment under the motto “Safe and Reassuring Surgery”.

Centers & Services